Search for: "WORD v. PFIZER, INC. et al" Results 1 - 20 of 24
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
30 Nov 2015, 3:34 am
 Never Too Late 70 [week ending on Sunday 1 November] –  Case T-309/13 Enosi Mastichoparagogon Chiou v OHIM, Gaba International Holding GmbH | Sixteen millions IPKats | Tomaydo-Tomahhdo LLC v George Vozray et al | Lookalike packaging | Parasite copying | 3D printing | Labouring the point? [read post]
16 Jul 2015, 4:00 am by Martin Kratz
Gould et al. (1983), 70 C.P.R. (2d) 11 (FCA). [read post]
25 Apr 2015, 11:03 am by Schachtman
See also Manual at 614 n. 198., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
13 Apr 2014, 8:59 am by Barry Sookman
Sanofi-Synthelabo Canada Inc., [2008] 3 SCR 265 At the outset, it is appropriate to refer to the words of Judson J. for this Court in Commissioner of Patents v. [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
14 Mar 2013, 4:00 am by Administrator
” otherwise “. . . the court may be heading into unknown waters without a chart.[429] An example of an application of this reading of Free World can be found in Pfizer Canada Inc. v. [read post]
23 Jan 2013, 1:02 am by W.F. Casey Ebsary, Jr.
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued October 16, 2012 Decided January 22, 2013 No. 11-1265 AMERICANS FOR SAFE ACCESS, ET AL., PETITIONERS v. [read post]
23 Jan 2013, 1:02 am by W.F. Casey Ebsary, Jr.
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued October 16, 2012 Decided January 22, 2013 No. 11-1265 AMERICANS FOR SAFE ACCESS, ET AL., PETITIONERS v. [read post]
3 Mar 2012, 5:36 pm by Schachtman
Minn. 2008)(noting that some but not all courts have concluded relative risks under two support finding expert witness’s opinion to be inadmissible) XYZ, et al. v. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]